Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-10-04FDA Approved: RASAGILINE MESYLATE — Original Application (Avet Pharmaceuticals Inc.)
The FDA approved Avet Pharmaceuticals' original application for rasagiline mesylate as a generic treatment option for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: Fesoterodine on Urgency Episodes in Parkinson's Disease Population [Phase 4]
Phase 4 trial update on fesoterodine for urgency episodes in Parkinson's disease; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Nintendo WII and Exercises at Rehabilitation of Individuals With Parkinson's Disease [NA]
Clinical trial update on using Nintendo Wii exercises for individuals with Parkinson's disease; study completed with results posted.
-
FDA approval · 2019-08-29FDA Approved: INBRIJA — Supplemental Application (Merz Pharmaceuticals, LLC)
The FDA approved a supplemental application for INBRIJA (levodopa) from Merz Pharmaceuticals, LLC. The action updates the approved product, …
-
FDA approval · 2019-08-27FDA Approved: NOURIANZ — Original Application (Kyowa Kirin, Inc.)
FDA approved NOURIANZ (istradefylline) as an add-on therapy to levodopa/carbidopa for adults with Parkinson's disease to reduce off time.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-08-19FDA Approved: ZELAPAR — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for Zelapar (selegiline hydrochloride) submitted by Bausch Health US, LLC.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Clinical Outcomes of Deep Brain Stimulator (DBS) Electrodes Placed Using Intraoperative Computed Tomography (CT) and Frameless Stereotaxis [NA]
A completed clinical trial evaluating deep brain stimulator electrode placement using intraoperative CT and frameless stereotaxis in Parkins…
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: Acupuncture for Fatigue in Parkinson's Disease [NA]
Clinical trial investigating acupuncture for fatigue in Parkinson's disease has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease [Phase 2]
Phase 2A study of GM 608 in mild to moderate Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients [Phase 3]
Phase 3 trial update assessing safety and efficacy of a gastric-retentive formulation (AP-CD/LD) in advanced Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes [Phase 3]
Phase 3 clinical trial results for CVT-301 in Parkinson's disease patients with OFF episodes have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Telemedicine Intervention to Improve Cognitive Function [NA]
A completed clinical trial investigated a telemedicine intervention to improve cognitive function in individuals with Parkinson's disease, w…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Evaluation of the Efficacy and Safety of Bumetanide in Parkinson's Disease [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of bumetanide in Parkinson's disease is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods. [Phase 2, Phase 3]
Clinical trial update for apomorphine nasal powder in Parkinson's disease focusing on 'off' periods, spanning Phase 2 and Phase 3 and comple…
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease [Phase 3]
Phase 3 clinical trial update for subcutaneous apomorphine infusion in advanced Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: the Efficacy and Safety of Agomelatine in the Patients With Parkinson's Disease [Phase 4]
Phase 4 trial evaluating the efficacy and safety of agomelatine in patients with Parkinson's disease and depression.
-
FDA approval · 2019-06-05FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's Original Abbreviated New Drug Application for Carbidopa and Levodopa (generic). The product i…
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Modulation of Gut Microbiota by Rifaximin in PD Patients [Phase 1, Phase 2]
Early-phase clinical trial update evaluating rifaximin to modulate gut microbiota in Parkinson's disease patients with inflammatory consider…
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease [Phase 2]
Phase 2 trial assessing repeated-dose oral N-acetylcysteine for treating Parkinson's disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease [Phase 2]
Phase 2 trial investigating safety and efficacy of NTCELL immunoprotected porcine choroid plexus cells for xenotransplantation in Parkinson'…
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Mirabegron in Parkinson Disease and Impaired Cognition [Phase 4]
Phase 4 clinical trial update on mirabegron in Parkinson disease and impaired cognition with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease. [Phase 3]
Phase 3 trial update on safety and tolerability of tozadenant as adjunctive therapy in levodopa-treated patients with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: The Effects of Dual Task Training in Individuals With Parkinson's Disease [NA]
A completed clinical trial studying the effects of dual task training in individuals with Parkinson's disease; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-19Clinical Trial Update: A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants [Phase 3]
A completed Phase 3 study evaluating TVP-1012 (1 mg) in levodopa-treated Parkinson's disease patients; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Short Pulse Width DBS in Parkinson's Disease [Phase 2]
Phase 2 clinical trial update evaluating short pulse width deep brain stimulation in Parkinson's disease has completed.